Market News AIOpen the app

Oramed Pharmaceuticals is changing its rules to settle a class action lawsuit and avoid legal fees.

RulesRead the original at SEC EDGAR
Neutral

The case ended after a bylaw change and a $125,000 fee payment without an admission of fault. These legal steps settle the dispute, but the filing gives no sign they changed Oramed's business outlook.

ORMP · Oramed Pharmaceuticals Inc.

AI read · Neutral

The AI's read

The company said it changed its bylaws to avoid the distraction and cost of more litigation. It denied that the old rules broke the law and paid the legal fees without admitting fault. The case is closed, and the filing does not describe a change to Oramed's business outlook.

Get alerts for ORMP

Follow Oramed Pharmaceuticals Inc. (ORMP) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ORMP
Free on the App Store and Google Play, or on the web.